Order Article Reprints

Pishas KI, Cowley KJ, Pandey A, Hoang T, Beach JA, Luu J, Vary R, Smith LK, Shembrey CE, Rashoo N, et al. Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer. Cancers. 2021; 13(22):5644. https://doi.org/10.3390/cancers13225644

Pishas, Kathleen I., Karla J. Cowley, Ahwan Pandey, Therese Hoang, Jessica A. Beach, Jennii Luu, Robert Vary, Lorey K. Smith, Carolyn E. Shembrey, Nineveh Rashoo, and et al. 2021. "Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer" Cancers 13, no. 22: 5644. https://doi.org/10.3390/cancers13225644

Pishas, K. I., Cowley, K. J., Pandey, A., Hoang, T., Beach, J. A., Luu, J., Vary, R., Smith, L. K., Shembrey, C. E., Rashoo, N., White, M. O., Simpson, K. J., Bild, A., Griffiths, J. I., Cheasley, D., Campbell, I., Bowtell, D. D. L., & Christie, E. L. (2021). Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer. Cancers, 13(22), 5644. https://doi.org/10.3390/cancers13225644